Environmentally induced autoimmune diseases: Potential mechanisms

被引:48
作者
Rao, T
Richardson, B
机构
[1] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA
[2] Vet Affairs Hosp, Dept Med, Ann Arbor, MI USA
关键词
anergy; autoimmunity; deletion; mechanisms; suppression; tolerance; xenobiotic;
D O I
10.2307/3434335
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Environmental and other xenobiotic agents can cause autoimmunity. Examples include drug-induced lupus, toxic oil syndrome, and contaminated L-tryptophan ingestion. Numerous mechanisms, based on in vitro evidence and animal models, have been proposed to explain how xenobiotics induce or accelerate autoimmunity. The majority of these can be divided into three general categories. The first is those inhibiting the processes involved in establishing tolerance by deletion. Inhibiting deletion can result in the release of newly generated autoreactive cells into the periphery. The second mechanism is the modification of gene expression in the cells participating in the immune response, permitting lymphocytes to respond to signals normally insufficient to initiate a response or allowing the antigen-presenting cells to abnormally stimulate a response. Abnormal gene expression can thus disrupt tolerance maintained by suppression or anergy, permitting activation of autoreactive cells. The third is the modification of self-molecules such that they are recognized by the immune system as foreign. Examples illustrating these concepts are presented, and related mechanisms that have the potential to similarly affect the immune system are noted. Some mechanisms appear to be common to a variety of agents, and different mechanisms appear to produce similar diseases. However, evidence that any of these mechanisms are actually responsible for xenobiotic-induced human autoimmune disease is still largely lacking, and the potential for numerous and as yet unidentified mechanisms also exists.
引用
收藏
页码:737 / 742
页数:6
相关论文
共 89 条
  • [1] AHMED SA, 1985, J IMMUNOL, V134, P204
  • [2] PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO
    ALESSI, DR
    CUENDA, A
    COHEN, P
    DUDLEY, DT
    SALTIEL, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) : 27489 - 27494
  • [3] Apte RS, 1998, J IMMUNOL, V160, P5693
  • [4] EFFECT OF PROCAINAMIDE AND HYDRALAZINE ON POLY (ADP-RIBOSYLATION) IN CELL-LINES
    AYER, LM
    EDWORTHY, SM
    FRITZLER, MJ
    [J]. LUPUS, 1993, 2 (03) : 167 - 172
  • [5] AN INVESTIGATION OF THE CAUSE OF THE EOSINOPHILIA-MYALGIA SYNDROME ASSOCIATED WITH TRYPTOPHAN USE
    BELONGIA, EA
    HEDBERG, CW
    GLEICH, GJ
    WHITE, KE
    MAYENO, AN
    LOEGERING, DA
    DUNNETTE, SL
    PIRIE, PL
    MACDONALD, KL
    OSTERHOLM, MT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (06) : 357 - 365
  • [6] CLONING AND SEQUENCING OF A CDNA-ENCODING DNA METHYLTRANSFERASE OF MOUSE CELLS - THE CARBOXYL-TERMINAL DOMAIN OF THE MAMMALIAN ENZYMES IS RELATED TO BACTERIAL RESTRICTION METHYLTRANSFERASES
    BESTOR, T
    LAUDANO, A
    MATTALIANO, R
    INGRAM, V
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1988, 203 (04) : 971 - 983
  • [7] REVERSAL OF INVITRO T-CELL CLONAL ANERGY BY IL-2 STIMULATION
    BEVERLY, B
    KANG, SM
    LENARDO, MJ
    SCHWARTZ, RH
    [J]. INTERNATIONAL IMMUNOLOGY, 1992, 4 (06) : 661 - 671
  • [8] Helper T cell differentiation is controlled by the cell cycle
    Bird, JJ
    Brown, DR
    Mullen, AC
    Moskowitz, NH
    Mahowald, MA
    Sider, JR
    Gajewski, TF
    Wang, CR
    Reiner, SL
    [J]. IMMUNITY, 1998, 9 (02) : 229 - 237
  • [9] BONOMO A, 1995, J IMMUNOL, V154, P6602
  • [10] BUCY RP, 1993, J IMMUNOL, V151, P1039